Saving changes...

Done

Error

Cannabinoid and Endocannabinoid Medicine Training Program

Cannabinoid and Endocannabinoid Medicine Training Program

Cannabinoid and Endocannabinoid Medicine Training Program

Rachel Melissa Knox, MD, MBA
Rachel Melissa Knox, MD, MBA
on behalf of National University of Health Sciences

$500.00 $ 500.00 $ 500.00

$500.00 $ 500.00 $ 500.00

$ 500.00 $ 500.00 $ 500.00
$ 500.00 $ 500.00 $ 500.00
Normal Price: $500.00 $500.00

Review:

Launch date: 23 Apr 2020
Expiry Date:

Last updated: 26 Sep 2020

Reference: 195430

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

Sharon Herene (13 May 2020)
Thanks for making the course available!

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

These modules are designed to give you foundational knowledge and history of Cannabis, provide you information on the plant science and processing, teach you on Cannabis in Self-Directed Care & The Influence of Pharmacokinetics, discuss the Endocannabinoid System and an introduction to Cannabis Medicine.

Objectives

Module 1: The Vital History of Cannabis
Review the ancient origins of cannabis medicine.
Discuss the medical use of cannabis in the US prior to the 20th century.
Review the history of US federal legislation, prohibition, and criminalization of cannabis in the 20th century.
Explain the origins and reasoning behind the opposing positions in the debate about cannabis and cannabis medicine in the US in the 20th century.
Discuss the sequence of scientific findings that led to the discovery of the Endocannabinoid System (ECS).
List the major components of the Endocannabinoid System (ECS).
Discuss the beginnings of legalization and decriminalization of medical cannabis and cannabis in the US at the end of the 20th century.
Module 2: Plant Science & Processing
Recognize the taxonomy of the cannabis plant and describe the different subspecies.
Understand why using the term “cannabis” and avoiding the use of the term ‘marijuana’ is prudent for healthcare professionals.
Describe the reason the terms “strains” and “cultivars” are problematic or insufficient in describing the different varieties of cannabis.
Define and describe chemovars.
Define and describe cannabinoids, terpenes, terpenoids, flavonoids, and the additional components and chemical compounds of cannabis.
Define and describe hemp.
Differentiate between the colloquial use of cannabis and hemp.
Describe basic cultivation and production practices

Module 3: Cannabis in Self-Directed Care & The Influence of Pharmacokinetics
Explain the pitfalls of drawing a distinction between medical cannabis and recreational cannabis.
Explain the risks of legalizing cannabis for medical purposes prior to educating clinicians.
Describe the reasons patients turn to self-directed care when trying cannabis treatment.
Describe the sources patients turn to for information on cannabis treatment.
List the different ways patients access cannabis.
Describe the problems that arise when patients purchase cannabis under selfdirected care.
List and describe the common routes of administration that cannabis patients may use.
Describe the different dosing methods of cannabis.
Module 4: The Endocannabinoid System (ECS)
Recount the history of the discovery of the endocannabinoid system (ECS).
Explain the role and significance of the ECS for human health.
Identify the principal components of the ECS.
Explain the difference between CB1 and CB2 receptors.
Explain the function of the primary endogenous ligands of the ECS.
Compare the chemical structures of the endogenous ligands.
Explain the basic chemistry of endocannabinoid signaling.
Discuss examples of some medical conditions currently known to be related to ECS dysfunction or deficiency.
Module 5: Introduction to Cannabis Medicine | Synthesizing a Foundation
Describe the pharmacodynamics of THC.
Describe the common effects of THC experienced by patients.
Describe the pharmacodynamics of CBD.
Describe the common effects of CBD that patients experience.
List the different minor cannabinoids.
Describe terpenes.
Describe and understand the difference between monoterpenes, sesquiterpenes, and triterpenoids.
Describe flavonoids.
Understand the difference between flavones, flavonols, and flavanones.
Describe the difference between using the whole plant versus isolates for treatment.
Describe the role of the biphasic curve in treatment.
Describe Marinol (generic name: dronabinol) and Cesamet (generic name: nabilone).
Define the CBD:THC ratio.
Explain the synergistic effect of THC and CBD.
List the different types of cannabis products.
Explain the significance of lab testing and labeling.
Describe the areas of information that lab testing should cover.
Describe why testing and labeling is relevant to consumer safety and patient care.
Rachel Melissa Knox, MD, MBA

Author Information Play Video Bio

Rachel Melissa Knox, MD, MBA
on behalf of National University of Health Sciences

Dr. Rachel Knox, MD, MBA is a certified Cannabinoid Medicine specialist who received her medical and business degrees from Tufts University after completing her undergraduate studies at Duke. She trained in Family and Integrative Medicine before pursuing additional study in the areas of Functional Medicine, Cannabinoid Medicine, and Endocannabinology - the study of the function, dysfunction and modulation of the most important physiologic system in the human body, the endocannabinoid system.

She is passionate about educating her professional peers and broader public about the safety and effectiveness of Cannabinoid Medicine, the evidence-based clinical integration of Endocannabinology with Cannabinology, the study of the pharmacology of cannabinoids and other cannabimimetics. She believes that industry-wide engagement is necessary to maintain the highest standards of care and oversight, from seed to use, in the service of providing education and compassionate, wholly informed care to patients everywhere. This passion extends into further educating communities of color in the role cannabis can play in addressing the Minority Health Disparity Gap, and the broader way in which cannabis can impact the physical, spiritual, social, economic and political wellness of these communities.

As a Cannabinoid Medicine specialist and endocannabinologist who has counseled several thousand patients in cannabis therapeutics, she has seen first-hand how significant a role cannabis and cannabimimetic modalities play in helping patients reclaim their health and overall sense of wellness, establishing renewed ownership over their lives. She has witnessed her patients safely use cannabis as adjunctive therapy to their conventional treatment plans, to wean from prescription drugs, find relief from the side effects of toxic therapies, or avoid conventional pharmaceuticals altogether.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

This course is valid for continuing education credit in the following states, so long as it falls within the scope of practice as outlined by the corresponding state board:
CO, CT, DE, DC, GA, ID, IL, IA, MD, MI, MT, NE, OH, OR, RI, SC, UT, VT, VA, WA

PACE (8790): AK, ME, MN, NV, NC, ND, SD

If your state is not listed, please check approved continuing education through your respective state board, or contact our offices.

Please note that online continuing education is not recognized in the following states:
FL, IN, KY, LA, MS, OK, WI, WY

NUHS makes no representation either directly or indirectly that the substantive matter being presented is approved or within respective scope of licensing. It remains the attendees' responsibility to contact the state board(s) from which they seek continuing education credits for purposes of ensuring said board(s) approves both the delivery method and content as they relate to this event.

[email protected] | (630) 889-6622

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (1)

Go Back
Sharon Herene (13 May 2020)
Thanks for making the course available!

Loading...


Saving changes...

Done

Error